In The News
Slater & Gordon refers former employee to police over email with salary data
Non-compete clauses to get ax for employees earning under $175,000
Ex-Spotlight producer Taylor Auerbach sues Seven over Lehrmann comments
PwC settles former tax partner’s case over retirement payments
Lawyer accused of attempted blackmail wins round against Canberra firm
Chief of staff to Deputy PM Richard Marles drops bullying case
Beckman Coulter shoots down biotech’s stem cell trade mark
‘Egregious failure’ by lender’s counsel in appeal against ASIC win: court
CIMIC class action funder asks court to rule on hypothetical commission
Security contractors G4S, GEO targeted in cross-claim in detention class action
Please login to bookmark Close

US lab products giant Beckman Coulter has successfully opposed an Australian biotech’s bid to trade mark ‘Cytophex’ for its stem cell expansion system, with an IP Australia delegate finding the mark is too similar to Beckman’s ‘CytoFLEX’ mark. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au